LFCR Lifecore Biomedical, Inc.
$6.37▼ -2.38%
Healthcare
Other
Volume 841.6K
Avg Volume (10D) 440.0K
Key Metrics & Fundamentals
Market Cap
$241.27M
P/E Ratio
–
Div Yield
0.00%
52W Range
3.63 - 8.98
% vs 50 MA
21.09%
% vs 200 MA
18.15%
RSI-14
74.6
MACD Histogram
-0.0600
Beta (1Y vs SPY)
0.51
Free Cash Flow
-$2.70M
Gross Rev
$34.17M
Gross Profit
$12.08M
EBITDA
$5.34M
COGS
$22.09M
Operating Exp
$9.51M
Operating Income
$2.57M
EBIT
$2.57M
Pretax Income
-$6.13M
Net Income
-$6.16M
EPS (Diluted)
-0.19
Price & Volume History
Loading chart…
Recent News
Braemar Unveils Highly Qualified Independent Board Slate for Company’s New Chapter
Business Wire · Oct 26, 2026 7:00 AM ET
Is Lifecore Biomedical (LFCR) an Asymmetric Risk-Reward in Pharma Contract Manufacturing?
Insider Monkey · Oct 23, 2026 1:34 PM ET
Lifecore Biomedical to Participate at Upcoming Industry Conferences
GlobeNewswire · Oct 7, 2026 4:05 PM ET
Lifecore Extends Manufacturing Contract With Alcon Research
MT Newswires · Sep 29, 2026 5:36 PM ET
Barrington Downgrades Lifecore Biomedical to Market Perform From Outperform, Removes $6.25 Price Target
MT Newswires · Sep 29, 2026 7:38 AM ET
Craig-Hallum Downgrades Lifecore Biomedical to Hold From Buy, Adjusts PT to $6.28 From $9
MT Newswires · Sep 29, 2026 6:01 AM ET
William Blair Downgrades Lifecore Biomedical to Market Perform From Outperform
MT Newswires · Sep 29, 2026 6:00 AM ET
Top Midday Gainers
MT Newswires · Sep 28, 2026 1:05 PM ET
Lifecore Biomedical to Be Acquired by Webster Equity Partners for Up to $663 Million
MT Newswires · Sep 28, 2026 9:29 AM ET
Lifecore Biomedical to be Acquired by Webster Equity Partners
GlobeNewswire · Sep 28, 2026 8:45 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See LFCR's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.